Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-01

Clinical Trial Update: Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay [NA]

View source ↗

Summary

This clinical trial update describes the activity and content of Factor VIII in human plasma and assesses a novel immunoassay for measuring FVIII.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Factor VIII (Factor VIII)

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Hemophilia A | NA | Status: COMPLETED